bioRxivNeurosciencePreprint
Histone hyperacetylation-linked upregulation of KRAB zinc finger proteins impedes glial differentiation in Huntington's disease
Peter BrøggeriD, John N. MarianiiD, Dennis Salinas, Benjamin ManskyiD, Steven J. SchanziD, Nguyen P.T. HuynhiD, Rossana FotiiD, Steven A. GoldmaniD
Abstract
Glial differentiation is impaired in Huntington disease (HD), contributing to both the synaptic dysfunction and hypomyelination of HD. Through combined epigenomic and transcriptomic profiling, we found that glial progenitor cells (hGPCs) generated from HD-derived human embryonic stem cells exhibit persistent histone hyperacetylation, enabling the ectopic expression of a broad set of KRAB zinc finger protein (KZFP) transcriptional repressors. Single-cell RNA-Seq analysis of HD hGPCs revealed that their aberrant KZFP expression was attended by the persistent expression of neural progenitor-stage genes relative to wild-type hGPCs. The HD hGPCs over-expressed the MYST family histone acetyltransferase KAT6B, which led to their hyperacetylation at H3K9 and associated DNA demethylation, and displayed abnormally open chromatin, particularly at promoters of chromosome 19 KZFP gene clusters. Among those KZFPs most differentially activated in HD hGPCs was the primate-specific ZNF98, whose overexpression in wild-type hGPCs recapitulated the HD-associated suppression of glial development. These data implicate abnormal histone hyperacetylation in HD glial progenitor cells, and its associated over-expression of recently evolved KZFP transcriptional repressors, as a critical mechanism by which both astrocytic and oligodendrocytic differentiation are impaired in HD.
- organism: human
- assay: scRNA-seq
- research focus: differential expression
- approach: statistical model
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Transcriptional and Histone acetylation changes associated with CRE elements expose key factors governing the regulatory circuit in early stage of Huntington's disease models.
Sandra Arancibia-Opazo, Sebastián Contreras-Riquelme, … Mauricio Sáez·International Journal of Molecular SciencesPeer-reviewed·Jun 29, 2023
- Integrated transcriptome analysis of Huntingtons disease iPSC-derived and mouse astrocytes implicates dysregulated synaptogenesis, actin, and astrocyte maturation
Andrea M. Reyes-Ortiz, Edsel M. Abud, … Leslie Michels Thompson·bioRxiv·Jul 28, 2022
- EPIGENETIC REPROGRAMMING OF CELL IDENTITY IN THE RAT PRIMARY NEURON-GLIA CULTURES INVOLVES HISTONE SEROTONYLATION
Anastasia A. Borodinova, Yulia A. Leontovich, … Pavel M. Balaban·CellsPeer-reviewed·Jun 15, 2025
- Huntingtin loss-of-function contributes to transcriptional deregulation in Huntington's disease
Emilia Kozłowska, Agata Ciołak, … Agnieszka Fiszer·Cell & BiosciencePeer-reviewed·Jul 9, 2025
- Selective inhibition of histone deacetylase 1 and 3 improves motor phenotype and alleviates transcriptional dysregulation in Huntington's disease mice
Katharina Hecklau, Susanne G. Mueller, … Ferah Yildirim·bioRxiv·Oct 13, 2020
- Epigenetic mechanisms governing cell type specific somatic expansion and toxicity in Huntington's disease
Matthew Baffuto, Kert Mätlik, … Nathaniel Heintz·bioRxiv·May 21, 2025